Rinofluimucil nasal spray. (vial of dark glass) 10ml per set with spray # 1
Category
Runny nose
Scope of the drug
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Italy
Package quantity, pcs
one
Release form, composition and packaging
?
Nasal spray in the form of an almost colorless transparent liquid with a characteristic mint slightly sulfurous odor.
1 ml
acetylcysteine 10 mg
tuaminoheptane sulfate 5 mg
benzalkonium chloride, hypromellose, disodium edetate, sodium dihydrogen phosphate, sodium hydrogen phosphate dodecahydrate, dithiothreitol, sorbitol 70%, mint flavor, ethanol 96%, sodium hydroxide, purified water.
10 ml - dark glass vials (1) complete with a spray nozzle - cardboard packs.
pharmachologic effect
A drug with a mucolytic and vasoconstrictor effect for use in ENT practice.
Acetylcysteine liquefies mucous and purulent-mucous secretions by breaking disulfide bonds of mucus glycoproteins.
It also has anti-inflammatory (due to inhibition of leukocyte chemotaxis) and antioxidant effect.
Tuaminoheptane sulfate is a sympathomimetic amine that, when applied topically, has a vasoconstrictor effect.
Eliminates swelling and hyperemia of the nasal mucosa.
Pharmacokinetics
When applied topically in recommended doses, the drug is not absorbed.
Indications for use
- acute and subacute coryza with thick purulent-mucous secretion
- chronic rhinitis
- vasomotor rhinitis
- sinusitis.
Contraindications for use
- angle-closure glaucoma
- thyrotoxicosis
- simultaneous use of MAO inhibitors and a period of up to 14 days after their cancellation
- simultaneous use of tricyclic antidepressants and a period of up to 14 days after their cancellation
- hypersensitivity to drug components.
The drug is prescribed with caution to children under the age of 3 years, patients with bronchial asthma, arterial hypertension, angina pectoris of III-IV functional classes, frequent extrasystole (treatment should be carried out under medical supervision).
Dosage regimen
The drug is injected into the nasal cavity in the form of an aerosol using a special nebulizer.
Adults are injected with 2 doses of aerosol (2 pressing the valve) into each nasal passage 3-4 times / day.
For children, the drug is prescribed 1 dose of aerosol (1 press on the valve) in each nasal passage 3-4 times / day.
The duration of therapy should not exceed 7 days.
Do not exceed the recommended dose and course of treatment without consulting your doctor.
Rules for using the drug 1. Remove the cap from the solution bottle.
2. Remove the cap from the spray gun.
3. Remove the cap from the spray gun.
4. Activate the nebulizer by pressing again.
Overdose
Symptoms: it is possible to develop systemic side effects due to the tuaminoheptane, which is part of the drug (tachycardia, tremor, anxiety, increased blood pressure, addiction).
Treatment: if necessary, symptomatic therapy is performed.
Side effect
From the side of the cardiovascular system: palpitations, tachycardia, arterial hypertension.
From the side of the central nervous system: rarely - agitation, tremor.
Local reactions: dryness of the mucous membrane of the nasal cavity, mouth and pharynx.
Others: rarely - allergic reactions, urinary retention, inflammation of the sebaceous glands.
With prolonged use of vasoconstrictors, it is possible to change the normal function of the mucous membrane of the nasal cavity and sinuses, as well as the development of addiction to the drug.
Drug interactions
When Rinofluimucil is used together with MAO inhibitors and tricyclic antidepressants, the likelihood of systemic side effects caused by tuaminoheptane increases (since these drugs potentiate the effect of sympathomimetic drugs).
With the simultaneous use of Rinofluimucil® can weaken the effect of antihypertensive drugs.
Application during pregnancy and lactation
The use of the drug during pregnancy and lactation is possible only in cases where the intended benefit to the mother outweighs the potential risk to the fetus and child.
Special instructions The drug is intended only for and
Name ENG
RINOFLUIMUCIL
Clinical and pharmacological group
A drug with mucolytic and vasoconstrictor action for topical use in ENT practice
ATX code
Tuaminoheptane in combination with other drugs
Dosage
1g + 500mg x 10ml
Structure
Active ingredients: acetylcysteine 1 g
tuaminoheptane sulfate 0.5 g. Excipients: benzalkonium chloride, methyl hydroxypropyl cellulose, disodium edetate, sodium dihydrogen phosphate monohydrate, disodium phosphate dodecahydrate, dithiotreitol, sorbitol 70%, mint flavor, purified ethanol 96%, sodium hydroxide.
Indications
Acute and subacute rhinitis with thick purulent-mucous secretion
chronic rhinitis
vasomotor rhinitis
sinusitis.
Storage conditions and periods
At a temperature of 15-25 degrees.
Expiration date: 2.5 years
INN / Active ingredient
Acetylcysteine, Tuaminoheptane Sulfate
Contraindications
Hypersensitivity to drug components
angle-closure glaucoma
thyrotoxicosis
the simultaneous use of tricyclic antidepressants and MAO inhibitors and a period up to 14 days after their cancellation.
With care: children under 3 years of age
with bronchial asthma
with arterial hypertension
with angina pectoris III-IV functional classes
with frequent extrasystole (treatment should be carried out under medical supervision).
Specifications
Category
Runny nose
Scope of the drug
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Italy
Package quantity, pcs
one
Minimum age from
1 year
Way of introduction
Through the respiratory tract
Vacation conditions
Without recipe
Volume, ml.
10 ml
Brand name
Zambon
Components
spray nozzle
The amount of the dosage form in the primary package
10 ml
Primary packaging type
Dark glass bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Decongestant
Anatomical and therapeutic characteristics
R01AB08 Tuaminoheptane, in combination with other drugs
Dosage form
Nasal spray
The target audience
Children
Expiration date in days
912
Dosage (volume) of the substance in the preparation
Acetylcysteine 1 g
tuaminoheptane sulfate 0.5 g
Package weight, g
80
Mode of application
:
The drug is injected into the nasal cavity in the form of an aerosol using a special nebulizer.
< br> Adults: inject 2 doses of aerosol (2 pressings on the valve) into each nostril 3-4 times / day. < br> Children: the drug is prescribed 1 dose (1 press on the valve) 3-4 times / day. < br> The duration of therapy should not exceed 7 days.
Shelf life after opening
:
After opening the bottle, the contents can be used within 20 days.
Information on technical characteristics, delivery set, country of manufacture